Medulloblastoma Journal Article
| Authors: | Millard, N. E.; De Braganca, K. C. |
| Article Title: | Medulloblastoma |
| Abstract: | Medulloblastoma accounts for nearly 10% of all childhood brain tumors. These tumors occur exclusively in the posterior fossa and have the potential for leptomeningeal spread. Treatment includes a combination of surgery, radiation therapy (in patients >3 years old). Patients >3 years old are stratified based on the volume of postoperative residual tumor and the presence or absence of metastases into "standard risk" and "high risk" categories with long-term survival rates of approximately 85% and 70%, respectively. Outcomes are inferior in infants and children younger than 3 years with exception of those patients with the medulloblastoma with extensive nodularity histologic subtype. Treatment for medulloblastoma is associated with significant morbidity, especially in the youngest patients. Recent molecular subclassification of medulloblastoma has potential prognostic and therapeutic implications. Future incorporation of molecular subgroups into treatment protocols will hopefully improve both survival outcomes and posttreatment quality of life. © SAGE Publications. |
| Keywords: | chemotherapy; medulloblastoma; embryonal tumor; pediatric brain tumor; posterior fossa mass |
| Journal Title: | Journal of Child Neurology |
| Volume: | 31 |
| Issue: | 12 |
| ISSN: | 0883-0738 |
| Publisher: | Sage Publications, Inc. |
| Date Published: | 2016-10-01 |
| Start Page: | 1341 |
| End Page: | 1353 |
| Language: | English |
| DOI: | 10.1177/0883073815600866 |
| PROVIDER: | scopus |
| PMCID: | PMC4995146 |
| PUBMED: | 26336203 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 2 November 2016 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
32De Braganca -
5Millard
Related MSK Work